An aging population, the medical service universal, demographic dividend disappear...... In a series of social progress in the process, the pharmaceutical industry become investment fields of the hottest plate. Medicine golden decade feast open, but suffered a series of cure of the policy.
The current issue of the financial weekly painted for you out in the present policy and policy trend medical, pharmaceutical industry within the pictures of the listed company.
Because the pharmaceutical industry segments involving many fields, this period we focused attention on the field in chemistry. This is not only the medical industry's biggest son plate,China medical thermometer manufacturer is also the most traditional, brought by the biggest impact on policy plates.
According to the classification shenyin &wanguo industry, the chemical raw materials and chemical preparation in two segments of the plates chemical pharmaceutical industries, is currently in A shares have 58 listed companies.
"Three head a tail" build advantage
In order to study the different views from 58 companies, and from our business sales market, research and development ability, product originality, the diversity of products of the company are evaluated.
Most PuYao type of chemical pharmaceutical company,China digital blood pressure monitor manufacturer is brought by the biggest impact on company policies, the advantage of a tail three heads of the competition has become the core component. The so-called three head refers to the endorsement of the barriers, policy areas barriers and technical barriers. Written instructions to a subordinate barriers refers to "the drugs register management method" in regulation 1-5 class chemical drug approved a 3-5 years of monitoring, this period is not approved, the administration's other factories, change and import dosage form. New drugs can obtain higher pricing, also can avoid intense price competition.China basal thermometer manufacturer Policy barriers means that in some areas of special drug pricing way, such as the national narcotics addiction to have a designated production policy, not intense competition. Don't need tender, formulated by the state supreme ex-works and retail price, price stability.
Is that a company production barriers level of patent research and development ability. Such as peptide drugs, the vasopressin and oxytocin the card technical barriers is higher,China upper arm blood pressure monitor manufacturer apply for manufacturers less. And John yu pharmaceutical production technology has the advantages of peptide on industrialization platform to realize the API to preparation from nationalization,China waterproof thermometer build give higher peptide field barriers.
Oligarchs marketing intensified
But most of the PuYao company will fire concentrated in marketing channel, this meant "one end", has the rich product specialist areas, good sales skills, strong drug development ability and the specialized subject resource input output can maximize. For example, in the infusion Aaron pharmaceutical industry, industry into the barrier is not high, and the transportation cost each company will all over in rodeos, local production. When the market has now progress to the oligarchs competition after the stage, in the infusion products use restrictions call more and more big, new business is the transformation of the mining company must face the difficulties of oligarchs.